➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Express Scripts
McKinsey
Moodys
Mallinckrodt

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

DESVENLAFAXINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Desvenlafaxine, and what generic alternatives are available?

Desvenlafaxine is a drug marketed by Alembic Pharms Ltd, Sun Pharma Global, Teva Pharms Usa, Actavis Labs Fl, Casi Pharms Inc, Hikma, Intellipharmaceutics, Lupin Ltd, Mylan, Yichang Humanwell, and Zydus Pharms. and is included in thirteen NDAs.

The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.

US ANDA Litigation and Generic Entry Outlook for Desvenlafaxine

A generic version of DESVENLAFAXINE was approved as desvenlafaxine succinate by ALEMBIC PHARMS LTD on June 29th, 2015.

  Start Trial

Drug patent expirations by year for DESVENLAFAXINE
Drug Prices for DESVENLAFAXINE

See drug prices for DESVENLAFAXINE

Recent Clinical Trials for DESVENLAFAXINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
H. Lundbeck A/SPhase 4
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3
Luye Pharma Group Ltd.Phase 1

See all DESVENLAFAXINE clinical trials

US Patents and Regulatory Information for DESVENLAFAXINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd DESVENLAFAXINE desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204150-001 Mar 4, 2013 RX Yes Yes   Start Trial   Start Trial   Start Trial
Intellipharmaceutics DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204805-001 May 7, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Yichang Humanwell DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 210014-001 Oct 1, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Labs Fl DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204065-001 Jul 29, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharma Global DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205583-002 Jan 28, 2014 DISCN Yes No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204003-002 Jun 29, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204172-001 Jun 29, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKinsey
Boehringer Ingelheim
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.